RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31324720http://www.w3.org/2000/01/rdf-schema#comment"Spleen tyrosine kinase (SYK) plays a major role in inflammation and in adaptive immune responses and could therefore contribute to the neuroinflammation observed in various neurodegenerative diseases. Indeed, previously we have reported that SYK also regulates β-amyloid (Aβ) production and hyperphosphorylation of Tau protein involved in these diseases. Moreover, SYK hyperactivation occurs in a subset of activated microglia, in dystrophic neurites surrounding Aβ deposits, and in neurons affected by Tau pathology both in individuals with Alzheimer's disease (AD) and in AD mouse models. SYK activation increases Tau phosphorylation and accumulation, suggesting that SYK could be an attractive target for treating AD. However, the mechanism by which SYK affects Tau pathology is not clear. In this study, using cell biology and biochemical approaches, along with immunoprecipitation and immunoblotting, quantitative RT-PCR, and ELISAs, we found that SYK inhibition increases autophagic Tau degradation without impacting Tau production. Using neuron-like SH-SY5Y cells, we demonstrate that SYK acts upstream of the mammalian target of rapamycin (mTOR) pathway and that pharmacological inhibition or knockdown of SYK decreases mTOR pathway activation and increases autophagic Tau degradation. Interestingly, chronic SYK inhibition in a tauopathy mouse model profoundly reduced Tau accumulation, neuroinflammation, neuronal and synaptic loss, and also reversed defective autophagy. Our results further suggest that the SYK up-regulation observed in the brains of individuals with AD contributes to defective autophagic clearance leading to the accumulation of pathogenic Tau species. These findings further highlight SYK as a therapeutic target for the treatment of tauopathies and other neurodegenerative proteinopathies associated with defective autophagic clearance."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.org/dc/terms/identifier"doi:10.1074/jbc.ra119.008033"xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/author"Yao H."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/author"Jin C."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/author"Crawford F."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/author"Mullan M."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/author"Paris D."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/author"Schweig J.E."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/author"Coppola K."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/name"J Biol Chem"xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/pages"13378-13395"xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/title"Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo."xsd:string
http://purl.uniprot.org/citations/31324720http://purl.uniprot.org/core/volume"294"xsd:string
http://purl.uniprot.org/citations/31324720http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31324720
http://purl.uniprot.org/citations/31324720http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31324720
http://purl.uniprot.org/uniprot/#_A0A0A0MQC7-mappedCitation-31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31324720
http://purl.uniprot.org/uniprot/#_A2A5Y6-mappedCitation-31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31324720
http://purl.uniprot.org/uniprot/#_B1AQW2-mappedCitation-31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31324720
http://purl.uniprot.org/uniprot/#_B1AQW4-mappedCitation-31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31324720
http://purl.uniprot.org/uniprot/#_B1AQW5-mappedCitation-31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31324720
http://purl.uniprot.org/uniprot/#_B1AQW6-mappedCitation-31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31324720
http://purl.uniprot.org/uniprot/#_E9PWE9-mappedCitation-31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31324720
http://purl.uniprot.org/uniprot/#_Q3V3Q2-mappedCitation-31324720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31324720